Home » Newsletters » BioWorld

BioWorld

April 6, 1994

View Archived Issues

IMMUNEX FILES NEW PLA FOR LEUKINE

BRITISH BIOTECH SHARES BUCK THE TREND

VIAGENE GETS $10M BOOST FROM GREEN CROSS

CORRECTION

SHEFFIELD TO START TESTING LIPOSOME-CD4

SYNTRO GETS OK FOR FIELD TRIAL

GENENTECH'S PHASE II RESULTS FOR PULMOZYME LOOK POSITIVE

GENENTECH, PCS HEALTH SYSTEMS LINK UP

APHTON RAISES $10.4 MILLION

NIH INVITES LICENSEES FOR AIDS DRUG FROM BORNEO TREE

ARCTURUS FILES FOR IPO

ALZHEIMER'S IMPROVES WITH COGNEX

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...